SEC Form 4/A · accession 0001209191-18-024836
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Nancy Stuart
Officer — Chief Operating Officer
Period of report
Mar 31, 2018
Accepted (ET)
Apr 13, 2018 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 31, 2018 | F | 4,418 | $22.90 | D | 121,376 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction represents withholding of shares to satisfy tax withholding obligations upon the vesting of restricted stock units.
- F2This amendment is being filed to reduce the number of securities beneficially owned by the reporting person by 15,000 shares of common stock due to the failure to achieve certain performance criteria set forth in the restricted stock unit grant agreement with the reporting person dated July 6, 2017.